申请人:Chambers Stuart Mark
公开号:US20050101586A1
公开(公告)日:2005-05-12
Compounds of formula I:
are antagonists of the human 5-HT
2A
receptor, and hence useful in treatment or prevention of a variety of neurological conditions.
式I的化合物:是人类5-HT2A受体的拮抗剂,因此在治疗或预防各种神经系统疾病方面很有用。